Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center — Hackensack, New Jersey

Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center has participated in 1 clinical trials.

Therapeutic areas: Wiskott-Aldrich Syndrome.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center?

Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center conducted?

Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center has 1 clinical trials on record. Their work covers Wiskott-Aldrich Syndrome.

Is Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center accredited by Crixeo Health?

Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.